Publications by authors named "Bart Winters"

Claim this Profile
U
Ultra-deep sequencing of HIV-1 reverse transcriptase before start of an NNRTI-based regimen in treatment-naive patients.
Peter Messiaen, Chris Verhofstede, Ina Vandenbroucke, Sylvie Dinakis, Veerle Van Eygen, Bart Winters

Virology· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic HIV-1 subtype C backbone generates comparable PR and RT resistance profiles to a subtype B backbone in a recombinant virus assay.
David Nauwelaers, Margriet Van Houtte, Bart Winters, Kim Steegen, Kurt Van Baelen

PLoS One· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequences.
Kim Steegen, Michelle Bronze, Elke Van Craenenbroeck, Bart Winters, Koen Van der Borght

AIDS Res Ther· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical cut-offs for HIV-1 phenotypic resistance estimates: update based on recent pivotal clinical trial data and a revised approach to viral mixtures.
Bart Winters, Elke Van Craenenbroeck, Koen Van der Borght, Pierre Lecocq, Jorge Villacian

J Virol Methods· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combined genotypic and phenotypic human immunodeficiency virus type 1 recombinant virus assay for the reverse transcriptase and integrase genes.
Kurt Van Baelen, Evelien Rondelez, Veerle Van Eygen, Kevin Ariën, Marleen Clynhens, Bart Winters

J Virol Methods· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advantages of predicted phenotypes and statistical learning models in inferring virological response to antiretroviral therapy from HIV genotype.
André Altmann, Tobias Sing, Hans Vermeiren, Bart Winters, Elke Van Craenenbroeck

Antivir Ther· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4-using HIV type 1 variants are more commonly found in peripheral blood mononuclear cell DNA than in plasma RNA.
Chris Verhofstede, Linos Vandekerckhove, Veerle Van Eygen, Els Demecheleer, Ina Vandenbroucke, Bart Winters

J Acquir Immune Defic Syndr· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological response to darunavir/ritonavir-based regimens in antiretroviral-experienced patients (PREDIZISTA study).
Isabelle Pellegrin, Linda Wittkop, Laurence Morand Joubert, Didier Neau, Diane Bollens, Bart Winters

Antivir Ther· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data.
Bart Winters, Julio Montaner, P Richard Harrigan, Brian Gazzard, Anton Pozniak

J Acquir Immune Defic Syndr· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of the M184V mutation in HIV-1 reverse transcriptase on the virological outcome of highly active antiretroviral therapy regimens with or without didanosine.
Michael Sproat, Anton L Pozniak, Monika Peeters, Bart Winters, Richard Hoetelmans

Antivir Ther· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis